Anti-osteoporotic activity of methanolic extract of an Indian herbal formula NR/CAL/06 in ovariectomized rats;(Chinese Source)

Journal of Chinese Integrative Medicine

Volumn 9, Issue 10, 2011, Pages 1123-1132

  Srikanta, Praveen ^a   Nagarajappa, Shivaprasad H ^b   Viswanatha, Gollapalle L ^a   Handral, Mukund ^a   Subbanna, Rajesh ^a   Srinath, Rangappa ^a   Hiremath, Ganesh ^a  

^a PES COLLEGE OF PHARMACY   (India)

^b Natural Remedies Pvt Ltd   (India)

Author keywords

Ayurvedic; Electron; Medicine; Microscopy; Osteoporosis; Ovariectomy; Plant extracts; Rats; Scanning

Indexed keywords

ALKALINE PHOSPHATASE; AYURVEDIC DRUG; CALCIUM; NR CAL O6; PHOSPHORUS; RALOXIFENE; UNCLASSIFIED DRUG; METHANOL; PLANT EXTRACT;

ADOLESCENT; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; BONE MINERAL; BONE STRENGTH; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FEMUR; NONHUMAN; OSTEOPOROSIS; OVARIECTOMY; PHOSPHATE BLOOD LEVEL; RAT; SCANNING ELECTRON MICROSCOPY; UTERUS WEIGHT; ANIMAL; BONE DENSITY; PHYTOTHERAPY; SPRAGUE DAWLEY RAT;

ANIMALS; BONE DENSITY; FEMALE; METHANOL; OSTEOPOROSIS; OVARIECTOMY; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 80054121537     PISSN: 16721977     EISSN: None     Source Type: Journal    
DOI: 10.3736/jcim20111014     Document Type: Article

References (21)

1. Canalis E, Giustina A, Bilezikian JP. Mechanisms of anabolic therapies for osteoporosis. N Engl J Med. 2007; 357(9): 905-916.
2. Heaney RP, Recker RR, Saville PD. Menopausal changes in bone remodeling. J Lab Clin Med. 1978; 92(6): 964-970.
3. McNamara LM, Ederveen AG, Lyons CG, Price C, Schaffler MB, Weinans H, Prendergast PJ. Strength of cancellous bone trabecular tissue from normal, ovariec-tomized and drug-treated rats over the course of ageing. Bone. 2006; 39(2): 392-400.
4. Basly JP, Lavier MC. Dietary phytoestrogens: potential selective estrogen enzyme modulators? Planta Med. 2005; 71(4): 287-294.
5. Mundy GR. Osteoporosis into the year 2010. Br J Obstet Gynaecol. 1996; 103(Suppl 13): 32-37.
6. Somekawa Y, Wakabayashi A. Relationship between apolipoprotein E polymorphism, menopausal symptoms, and serum lipids during hormone replacement therapy. Eur J Obstet Gynecol Reprod Biol. 1998; 79(2): 185-191.
7. Gambacciani M, Ciaponi M. Postmenopausal osteoporosis management. Curr Opin Obstet Gynecol. 2000; 12(3): 189-197.
8. Stepdn JJ, Musilovd J, Pacovsky V. Bone demineraliza-tion, biochemical indices of bone remodeling, and estrogen replacement therapy in adults with Turner's syndrome. J Bone Miner Res. 1989; 4(2): 193-198.
9. Goldstein SR, Siddhanti S, Ciaccia AV, Plouffe L Jr. A pharmacological review of selective oestrogen receptor modulators. Hum Reprod Update. 2000; 6(3): 212-224.
10. Gorman C, Park A. The truth about hormones. Time. 2002; 160(4): 32-39.
11. Vasudeva N, Sharma SK. Post-coital antifertility activity of Hibiscus rosasinensis Linn, roots. Evid Based Complement Alternat Med. 2008; 5(1): 91-94.
12. Ghosh A, Chowdhury N, Chandra G. Laboratory evaluation of a phytosteroid compound of mature leaves of Day Jasmine (Solanaceae: Solanales) against larvae of Culex quinque f asciatus (Diptera: Culicidae) and nontarget organisms. Parasitol Res. 2008; 103(2): 271-277.
13. Obolentseva GV, Litvinenko VI, Ammosov AS, Popova TP, Sampiev AM. Pharmacological and therapeutic properties of licorice preparations (A review). Pharm Chem J. 1999; 33(8): 24-31.
14. Vaya J, Belinky PA, Aviram M. Antioxidant constituents from licorice roots: isolation, structure elucidation and antioxidative capacity toward LDL oxidation. Free Radic Biol Med. 1997; 23(2): 302-313.
15. Tamir S, Eizenberg M, Somjen D, Izrael S, Vaya J. Estrogen-like activity of glabrene and other constituents isolated from licorice root. J Steroid Biochem Mol Biol. 2001; 78(3): 291-298.
16. Coxam V. New advances in osteoporosis nutritional prevention. Med Sci (Paris). 2005; 21(3): 297-301.
17. Fujioka M, Uehara M, Wu J, Adlercreutz H, Suzuki K, Kanazawa K, Takeda K, Yamada K, Ishimi Y. Equol, a metabolite of daidzein, inhibits bone loss in ovariectomized mice. J Nutr. 2004; 134 (10): 26232627.
18. Morin S. Isoflavones and bone health. Menopause. 2004; 11(3): 239-241.
19. Ke HZ, Chen HK, Simmons HA, Qi H, Crawford DT, Pirie CM, Chidsey-Frink KL, Ma YF, Jee WS, Thompson DD. Comparative effects of droloxifene, tamoxifen, and estrogen on bone, serum cholesterol, and uterine histology in the ovariectomized rat model. Bone. 1997; 20(1): 31-39.
20. 2, plasminogen activator, osteocalcin and alkaline phosphatase by osteoblast-like cells derived from human bone. Biochem Biophys Res Commun. 1990; 166(1): 208-216.
21. Einhorn TA. Bone strength: the bottom line. Calcif Tissue Int. 1992; 51(5): 333-339.